Scleroderma.

Slides:



Advertisements
Similar presentations
Scleroderma Nicole Bundy, MD, MPH Assistant Professor Division of Rheumatology and Immunology
Advertisements

XXXXXXXXXX Biology 1406 Class XXXXXX Fall 2010 Dr. Andrei Nesterovitch
Virginia Steen, MD Professor of Medicine
CREST J. Ryan Altman, MD AM REPORT 9 December 2009.
By: Aubrey Chinberg.  Scleroderma affects a person’s skin, blood vessels, muscles and internal organs  It is an autoimmune disorder.  Autoimmune disorders.
Autoimmune Diseases Dr. Raid Jastania. Autoimmune Diseases Group of diseases with common pathological process Presence of auto-antibody ?defect in B-cells.
Blood Vessels Frank A. Acevedo, PA-C. Vascular Abnormalities Narrowing of the lumen Thrombosis Weakening of the walls.
Vasculitides (Vasculitis) Dr. Raid Jastania. Vasculitis Inflammation of the walls of the vessels Causes of inflammation: –Infectious, physical, chemical,
SYSTEMIC CONNECTIVE TISSUE DISEASES DR CB NEL. INTRODUCTION Multiple body systems involved Wide spectrum of clinical manifestations Aetiology is multifactorial.
Scleroderma derived from greek and means hard skin
Systemic Sclerosis SCLERODERMA ד"ר גבריאל ש ברויאר היחידה לראומטולוגיה המרכז הרפואי שערי צדק.
GASTRO INTESTINAL DISORDERS Dr.linda maher. GIT(GASTRO INESTINAL TRACT)  it is a tube with muscle walls throughout its length. it is lined by an epithelium.
Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative van.
Raynaud’s Disease.
Part 1.  Cause Thrombus (blood clot) Embolism Trauma Crush injuries.
Physical hazards Dr Majid Golabadi.
Orthopaedics Wa’el N. Qa’dan, MSc. Rheumatoid arthritis (RA): It is the commonest cause of chronic inflammatory joint disease. Most typical.
Raynaud’s Disease or Raynaud’s Phenomenon
SCLERODERMA DEFINATION :-
Scleroderma (Systemic Sclerosis)
"On-line Atlas" of Dermatology and Rheumatology Cutaneous Manifestations of Rheumatic Diseases
Nursing Management: Arthritis and Connective Tissue Diseases
Rheumatoid Arthritis Dr ahad azami. Rheumatoid Arthritis Systemic Systemic Chronic Chronic Inflammatory Inflammatory Primarily targets the synovium of.
Good Morning ! October 3 rd,  An overlap syndrome associated with anti-U1-RNP (ribonucleic protein) antibodies with features of SLE, scleroderma,
-GOUT -Pseudogout Systemic sclerosis. A disease of Kings.
Classification of sclerodermas Localized sclerodermas Morhpea Linear scleroderma.
Differentiate Pulmonary arterial hypertension from pulmonary venous congestion.
CLINICAL MANIFESTATION OF SYSTEMIC SCLEROSIS
+ Raynaud’s Phenomenon By: Alison Cunliffe. + What is Raynaud’s Disease Condition resulting in a series of discolorations of the fingers and/or toes after.
Mixed Connective Tissue Disease
Examination skills of the musculoskeletal system Dr ARIANNIA.
Systemic Sclerosis (Scleroderma)
SCLERODERMA Gentleman’s Review Daniel Martingano OMSII.
Systemic Sclerosis ANAS MUHANNAa MD,FACR AL-QUDS UNIVERSITY
Introduction to collagen-vascular diseases. Definition: Rheumatologic (or Rheumatic) Disease: diseases characterized by pain and inflammation in joints.
Systemic Lupus Erythematosus (SLE). SLE Lupus is the latin word for “WOLF” Is an autoimmune disorder characterized by inflammation of almost any body.
Scleroderma Lab Data and Diagnosis Iraj Salehi-Abari MD., Internist
Scleroderma Raynaud’s phenomenon Iraj Salehi-Abari MD., Internist
Dr. Ashwin Kulkarni M.S.Ramaiah Medicial College Bangalore India
Systemic Sclerosis (Scleroderma)
Systemic sclerosis.
Scleroderma (Systemic Sclerosis)
Fig 1: Skin thickening and sclerodactyly Fig 2: Digital tip ulcers
Sjogren’s syndrome.
Objectives 1- Describe the clinical features and investigations of discoid lupus, subacute lupus , Systemic lupus erythematosus, systemic sclerosis, morphea.
VASOACTIVE DRUGS February 2017
Dr.Babur Salim Student in Rheumatology deptt. FFH
Arthritis All answers are TRUE for the T/F questions.
Systemic Sclerosis (Scleroderma)
Arthritis.
Diseases of the respiratory system lecture 5
Scleroderma Cutaneous features Iraj Salehi-Abari MD., Internist
“Mixed Connective Tissue Disease: Still Crazy After All These Years”
Systemic Lupus Erythematosis
Systemic Sclerosis Criteria.
Henoch–Schönlein Purpura (HEN-awk SHURN-line PUR-pu-ruh)
Gastrointestinal features
Research Project: The outcome of African American patients with scleroderma in relationship to autoantibody, genetics and socioeconomic status Donna Swistowski,
Scleroderma Fibrosis and vascular changes Uncommon
Scleroderma Description: Scleroderma (Sclero= hardening, Derma=skin) is a chronic autoimmune disorder characterized by the hardening of the skin, shrinking.
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
Systemic Sclerosis (Scleroderma) AND MIXED CONNECTIVE TISSUE DISORDES ( MCTD ) By Dr. Zahoor.
54 Osteoarthritis.
Figure 1 Currently recognized factors that influence the development of scleroderma renal crisis Figure 1 | Currently recognized factors that influence.
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
By: M. Rustom Plastic Surgeon
Wounds in Rheumatic Diseases
Presentation transcript:

Scleroderma

Scleroderma Generalized disorder of connective tissue affecting the skin , connective tissue and vasculature Peak age 40 -50 yrs age Female 4 : male 1 Limited disease , diffuse disease , CREST syndrome ( calcinosis , Raynaud’s , esophageal involvement , sclerodactyly and talangiectasia _)

Calcinosis

Calcinosis

Calcification

Marked Calcification

Marked Calcification involving the muscle

Calcinosis with nodules

Raynaud’s phenomenon

Esophageal dilatation

Early Sclerodactyly

Early sclerodactyly

Late Sclerodactyly

Talangiectasia

Etiology and pathogenesis Unknown etiology ( no genetic , geographical or race association ) Environmental factors as exposure to silica , dust , vinyl chloride , hypoxia resins and trichloroethylene ) Skin infiltration by T lymphocyte and abnormal fibroblast activation lead to increased production of collagen type I which results in thickening , tightening and induration of the skin (sclerodactyly )

Etiology and pathogenesis Arterial and arteriolar narrowing due to initial proliferation and vessel wall inflammation Endothelial injury causes release of vasoconstrictor and platelet activation

Clinical features Sclerodactyly proximal to MCP Js Most patients are ANA positive 30 % of diffuse disease and 60 % of limited disease have Ab to topoisomerase I and centromere respectively

Clinical features Cutaneous changes : Raynaud’s phenomenon is universal Non pitting oedema of the fingers and the flexor tendon sheath , then the skin become taut and shiny and distal skin creases disappear Erythema and tortuous dilatation of capillary loops in nail fold bed

Non pitting oedema of the fingers

Erythema and tortuous dilatation of capillary loops in nail fold bed

Taut skin and shiny

Clinical features Cutaneous changes : Skin involvement restricted to sites distal to the elbow or knee is classified as limited disease Involvement proximal to the knee and elbow and on the trunk is classified as diffuse disease Tissue ischemia leading to skin ulceration over pressure area , pulp atrophy of the finger tips

Tissue ischemia , skin ulceration and pulp atrophy

Digital loss

Perioral scleroderma with furrowing

Perioral scleroderma with furrowing

Clinical features Musculoskeletal features : Arthralgia , morning stiffness , flexor tenosynovitis Restricted hand function Erosive arthropathy is unknown Muscle weakness and wasting are usually due to myositis

Clinical features Gastrointestinal features Reflux with erosive eosophagitis ( Dysphagia and odynophagia Early satiety and occasionally outlet obstruction Recurrent occult upper GI bleeding may indicate watermelon stomach which occur in 20% of patients

erosive eosophagitis

Clinical features Gastrointestinal features Malabsorption due to bacterial overgrowth and intermittent bloating , pain or constipation Autonomic neuropathy may cause pseudo – obstruction

Clinical features Cardiorespiratory features : Fibrosing alveolitis in patient with diffuse disease Pulmonary hypertension more in limited than diffuse disease

Clinical features Renal features : Hypertensive renal crisis is the main cause of death ( presented with malignant hypertension and renal failure )

Management and Prognosis Hypertensive renal crisis is treated by angiotensin converting enzyme inhibitors Avoidance of peripheral cold exposure Calcium antagonist (nifedipine , amlodipine ) or angiotensin II receptor antagonist ( valsartan ) may be used for Raynaud’s symptoms

Management and Prognosis For digital ischemia intermittent infusion of prostacyclin may be helpful Steroids and cytotoxic drugs are used in myositis or alveolitis D- penicillamine and Interferon gamma may be used in skin

Mixed connective tissue disease His is an overlap connective tissue disease with features of SLE , scleroderma and myositis Synovitis and edema of the hands in combination of Raynaud’s phenomenon and muscle pain / weakness Most patients have anti – ribonucleoprotein (RNP ) antibodies